Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

QGEN SHAREHOLDER REMINDER: Hagens Berman Notifies Investors in Qiagen (QGEN) of Firm's Ongoing Investigation Involving Possible Securities Law Violations

QGEN

Class-action law firm urges QGEN investors who have suffered significant losses to submit a loss form now to learn if they qualify to recover their investment losses

SAN FRANCISCO, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Hagens Berman notifies Qiagen N.V. (NYSE: QGEN) investors of the firm’s ongoing investigation of possible violations of federal securities laws. 

Relevant Holding Period: Before Oct. 8, 2019
Sign Up: www.hbsslaw.com/investor-fraud/QGEN
Contact An Attorney Now: QGEN@hbsslaw.com    
510-725-3000

Qiagen N.V. (QGEN) Investigation:

The investigation centers on whether Qiagen misrepresented or concealed regional demand for its molecular and genetic testing applications.

More specifically, on October 8, 2019, Qiagen warned that Q3 2019 net sales growth would only be 3%, or 40% lower than its initial projections, attributing the reduction to significantly weaker-than-expected developments in China.  The company also disclosed that it would be shifting its global operations organization to a regional manufacturing structure and taking a restructuring charge of $260 – $265 million.  Further, the company announced the abrupt resignation of its longtime Chairman and CEO Peer Schatz.

In response, the price of Qiagen shares steeply fell on October 8, 2019.

“We’re focused on investors’ losses and whether Qiagen falsely portrayed demand for its products,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Qiagen should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email QGEN@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

Primary Logo





×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.